Severity
Moderate
FDA Drug recall · Reported August 5, 2020
Lack of Processing Controls (lack of assurance of conformity to specifications).
MasterPharm LLC recalled Testosterone/Anastrozole Pellet 100/6 mg, 100 pellets per bottle, MasterPharm, 115-02 Lib… - a moderate-severity action.
Testosterone/Anastrozole Pellet 100/6 mg, 100 pellets per bottle, MasterPharm, 115-02 Lib… was recalled by MasterPharm LLC in August 5, 2020. Reason: Lack of Processing Controls (lack of assurance of conformity to specifications).. Check the official notice for the remedy. Verify recall #D-1441-2020 with the FDA Drug before acting.
The recall
MasterPharm LLC issued this moderate-severity FDA Drug recall-Lack of Processing Controls (lack of assurance of conformity to specifications)..
Sourced from official FDA Drug enforcement records. Verify recall #D-1441-2020 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1441-2020) was formally reported on August 5, 2020, with the manufacturer initiating the action on July 2, 2020. It is classified under Moderate severity (Class II), with a current status of Terminated. MasterPharm LLC is listed as the recalling firm, operating out of South Richmond Hill, NY. Federal records list the affected scope as 339 pellets.
The documented reason for this recall is: Lack of Processing Controls (lack of assurance of conformity to specifications). Distribution data in the federal record shows the product reached: Nationwide in the U.S.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 3,731 children & baby products recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
339 pellets
Related Recalls
6
0 from same agency
Testosterone/Anastrozole Pellet 100/6 mg, 100 pellets per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419 (866) 630-5600
Lack of Processing Controls (lack of assurance of conformity to specifications).
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-1441-2020 |
| Date reported | August 5, 2020 |
| Date initiated | July 2, 2020 |
| Recalling firm | MasterPharm LLC |
| Firm location | South Richmond Hill, NY |
| Affected scope | 339 pellets |
| Distribution | Nationwide in the U.S. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Xishentang Dongguan Trading Co, Ltd., dba Pretty-Life, of China · 2026-07-02
Diamond Wipes International, Inc. of Chino, California · 2026-07-02
· 2026-07-02
· 2026-07-02
Sanven Technology Ltd., dba Vevor, of Rancho Cucamonga, California · 2026-07-02
Compare this recall with AMASKY Nursing Pillows Recalled Due to Risk of Serious Inju… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported August 5, 2020. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.